Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 24, 1994 - Issue 3
26
Views
1
CrossRef citations to date
0
Altmetric
Original Article

On the reactions of the carbapenem, meropenem, in the soluble fraction of rat kidney

&
Pages 185-198 | Received 17 Feb 1993, Published online: 27 Aug 2009
 

Abstract

1. When meropenem (I) is incubated with the soluble fraction of rat kidney or its ultrafiltrate the carbapenem disappears at a rate of 50 nmol/min per g of kidney at pH 8-4 and 37°c.

2. In both cases the kinetics are inconsistent with the reaction being enzymic and the product has been shown to be a thiol.

3. The same reaction occurs in similar preparations from the kidney of several other mammalian species.

4. The reaction of meropenem with thiols has been investigated: only those having a vicinal amino group react rapidly.

5. The product of the reaction with cysteine has been characterized as the amide (III) of the latter with meropenoic acid (II), the carboxylic acid formed by the hydrolysis of the β-lactam ring of meropenem.

6. It is postulated that the destruction of meropenem in the soluble fraction of rat kidney occurs by the non-enzymic reaction of the carbapenem with endogenous cysteine or related thiols.

7. There is no evidence that this reaction can occur in vivo but it should be considered in the future design of carbapenems.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.